Lupin rises on reporting 18% rise in Q4 consolidated net profit

14 May 2021 Evaluate

Lupin is currently trading at Rs. 1213.50, up by 2.75 points or 0.23% from its previous closing of Rs. 1210.75 on the BSE.

The scrip opened at Rs. 1212.90 and has touched a high and low of Rs. 1218.00 and Rs. 1183.85 respectively. So far 49171 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1246.30 on 11-May-2021 and a 52 week low of Rs. 828.65 on 27-Jul-2020.

Last one week high and low of the scrip stood at Rs. 1246.30 and Rs. 1170.20 respectively. The current market cap of the company is Rs. 54935.17 crore.

The promoters holding in the company stood at 46.86 % while Institutions and Non-Institutions held 40.46 % and 12.69 % respectively.

Lupin has reported results for fourth quarter and year ended March 31, 2021. The company has reported a rise of 40.42% in its net profit at Rs 316.36 crore for the quarter under review as compared to Rs 225.29 crore for the same quarter in the previous year. However, total income of the company decreased by 4.15% at Rs 2,582.03 crore for Q4FY21 as compared Rs 2,693.79 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 18.15% in its net profit after taxes attributable to owners at Rs 460.36 crore for the quarter under review as compared to Rs 389.63 crore for the same quarter in the previous year. However, total income of the company decreased by 5.25% at Rs 3,841.32 crore for Q4FY21 as compared Rs 4,054.34 crore for the corresponding quarter previous year.

For the year ended March 31, 2021, the company has reported a rise of 72.99% in its net profit at Rs 1258.62 crore as compared to Rs 727.55 crore for the previous year. However, total income of the company decreased by 2.75% at Rs 11,185.02 crore for year under review as compared to Rs 11,500.85 crore for year ended March 31, 2020.

For the year ended March 31, 2021, on the consolidated basis, the company has reported net profit after taxes attributable to owners at Rs 1,216.53 crore against net loss of Rs 269.39 crore for the previous year. However, total income of the company decreased by 3.53% at Rs 15,299.25 crore for year under review against net loss of Rs 15,858.52 crore for year ended March 31, 2020.

Lupin Share Price

1614.30 19.40 (1.22%)
26-Apr-2024 15:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1501.90
Dr. Reddys Lab 6256.40
Cipla 1408.00
Zydus Lifesciences 949.50
Lupin 1614.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.